KVUE
Kenvue Inc.
20.94
USD
This page is just a preview of the data found in TrendSpider’s full version
Kenvue Inc. stock is up 6.84% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 0% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 07 Dec 19:07 | 16 Feb, 2024 | 21.00 | 100075 | ||
| 07 Dec 19:07 | 19 Jan, 2024 | 22.50 | 46428 | ||
| 07 Dec 19:08 | 16 Feb, 2024 | 21.00 | 3918 | ||
| 07 Dec 19:08 | 16 Feb, 2024 | 21.00 | 3918 | ||
| 07 Dec 19:10 | 19 Jan, 2024 | 22.50 | 46428 | ||
| 07 Dec 19:12 | 16 Feb, 2024 | 21.00 | 100075 | ||
| 07 Dec 19:18 | 16 Feb, 2024 | 21.00 | 100075 | ||
| 07 Dec 19:21 | 15 Dec, 2023 | 20.00 | 26607 | ||
| 07 Dec 19:26 | 19 Jan, 2024 | 20.00 | 14700 | ||
| 07 Dec 20:16 | 19 Jan, 2024 | 22.50 | 46428 |
We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.
